the effectiveness of herbion iceland moss syrup in the treatment of dry cough in children

Clicks: 274
ID: 247877
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #21 of 94 articles by views in scientific electronic archives

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The article presents the etiologic and pathogenetic aspects of the appearance of dry cough in children. Personal experience of using Herbion Iceland moss syrup in the treatment of post-infectious dry cough in children aged 4–10 years is described. Application of the drug has significantly reduced the intensity of dry cough, quickly stopped night coughing, improved the quality of life of children. Herbion Iceland moss syrup is well tolerated by children and does not cause adverse reactions when used.
Reference Key
niankovskyi2015zdorovethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;S.L. Niankovskyi;M.S. Yatsula;I.V. Babik;V.B. Yaskiv;O.I. Shpychka;B.V. Yandio
Journal scientific electronic archives
Year 2015
DOI
10.22141/2224-0551.7.67.2015.75086
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.